Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probio-Tec ABCG for Schizophrenia Patients
NCT04226898Phase 2Recruiting
- Sponsor
- Sheppard Pratt
- Start
- Feb 2022
- Primary completion
- Mar 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Probio-Tec ABCG-Stick-25 in schizophrenia, schizoaffective disorder, sponsored by Sheppard Pratt. Started Feb 2022; status: recruiting.
02
Drugs
Probio-Tec ABCG-Stick-25
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT04226898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04226898.